Addressing COVID-19 in At-Risk Populations with Underlying Co-Morbidities - 11/7/2023

Exploring the Ongoing Risk of Severe COVID-19 in At-Risk PopulationsПодробнее

The Chicago COVID-19 Comorbidities (C3) Cohort Study: Initial FindingsПодробнее

Сопутствующие заболевания и COVID | 9 худших рисков для здоровьяПодробнее

February 2023 ACIP Meeting - Benefit/risk for COVID-19 vaccinesПодробнее

Comorbidities and COVID-19Подробнее

Webinar 3: Caring for People with Serious Illness during the COVID-19 PandemicПодробнее

Testimony: Address Underlying Conditions That Makes COVID-19 DeadlyПодробнее

Addressing COVID-19 in Special Populations with Underlying Co-Morbidities | COVID's Lasting ImpactПодробнее

COVID 19 Update Update 106: Comorbidities and Excess Deaths; Bradykinin and CoronavirusПодробнее

Friday 1st May Comorbidities and symptoms reportПодробнее

Risk Ranking Of Everyday Activities For COVID-19, According To An Infectious-Disease ExpertПодробнее

Comorbidities and COVID-19Подробнее

Grieving families speak at COVID inquiry | Watch liveПодробнее

Co-morbidities & Covid: All you need to know | Your definitive guide to Covid-19Подробнее

Comorbid diseasesПодробнее

March 16, 2023 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)Подробнее

Highest deaths since 1929Подробнее

Underlying conditions and COVID-19Подробнее

UK Covid19 Inquiry - Module 4 Opening Submissions - 14 January 2025 PMПодробнее